Blue Trust Inc’s Ascendis Pharma A/S ASND Stock Holding History

Blue Trust Inc’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.3K	Hold	170	–	–	﹤0.01%	1382
2026 Q1	$38.9K	Sell	170 -157	-48%	-$35.2K	﹤0.01%	1430
2025 Q4	$69.7K	Hold	327	–	–	﹤0.01%	1224
2025 Q3	$65K	Hold	327	–	–	﹤0.01%	1276
2025 Q2	$56.4K	Sell	327 -41	-11%	-$6.68K	﹤0.01%	1386
2025 Q1	$57.4K	Sell	368 -39	-10%	-$5.57K	﹤0.01%	1272
2024 Q4	$56K	Buy	407 +328	+415%	+$43.1K	﹤0.01%	1251
2024 Q3	$10.8K	Buy	79 +13	+20%	+$1.76K	﹤0.01%	2172
2024 Q2	$9.98K	Buy	+66	New	+$8.98K	﹤0.01%	1928
2023 Q1	–	Sell	-6	Closed	-$1K	–	2294
2022 Q4	$1K	Sell	6 -1	-14%	-$116	﹤0.01%	2007
2022 Q3	$1K	Buy	+7	New	+$664	﹤0.01%	1878

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Blue Trust Inc's ASND Position: Q2 2026 in Review

Blue Trust Inc held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 170 shares worth $45.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1382.

Blue Trust Inc first reported a position in ASND in Q3 2022 and has held it in 11 quarters since. The position peaked at $69.7K in Q4 2025. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Blue Trust Inc held 170 shares of Ascendis Pharma A/S worth $45.3K as of Q2 2026.
Blue Trust Inc left its Ascendis Pharma A/S share count unchanged in Q2 2026.
Ascendis Pharma A/S made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1382 holding.
Blue Trust Inc first reported a position in Ascendis Pharma A/S in Q3 2022 and has held it in 11 quarters since.
Blue Trust Inc's Ascendis Pharma A/S position peaked at $69.7K in Q4 2025.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.